Therefore, the survival kinase Akt attracted major attention for the development of molecularly targeted approaches for the treatment of human solid tumors including prostate cancer and overcoming resistance to standard genotoxic chemo- and radiotherapy. The gene discussed is AKT1; the disease is prostate carcinoma.